Analysts are divided when it comes to Johnson & Johnson (NYSE:JNJ) stock. The medical device company experienced its share of ups and downs this year. It is currently one of many companies attempting to defend itself against ongoing opioid lawsuits. In August, an Oklahoma judge found Johnson & Johnson guilty of deceptive marketing practices and fined the company $572 million. The company allegedly marketed its opioid products as non-addictive, in spite of repeated warnings from the FDA.
The question for investors is, how important is this verdict and what will the ongoing lawsuit mean for JNJ stock? Here are three things you need to know about the opioid lawsuits. JNJ has been around for more than 130 years and is the largest healthcare company in the world. The company actively participates in nearly every aspect of the healthcare industry. That includes making consumer products, selling medical equipment, and making and distributing pharmaceuticals. So JNJ is a company that’s built to last. The opioid lawsuits will cause short-term problems for the company. JNJ stock has remained relatively flat over the last year and is up 2.4% in 2019. But the company should persevere in spite of its challenges.
Source: InvestorPlace
Related Articles:
- Why Dividend Growth Stocks Are Evil
- 4 Higher-Yielding Financial Services Stocks With Rising Dividends
- 5 Higher Yield Dividend Growth Stocks
- Successful Investors Take The Emotion Out
- 5 Under-Valued Dividend Growth Stocks
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Well-chosen dividend stocks are powerful wealth creators. They can add both growth and stability to your investment portfolio -- while putti...
-
High-yield stocks with low price-to-earnings ratios tend to do well over time. It’s also a good deal for investors when the earnings of the ...
-
Whenever a non-dividend-paying stock sets up a regular dividend policy, it is considered very, very good news. And that’s also why, whenever...
-
Dividend stocks are the Swiss army knives of the stock market. When dividend stocks go up, you make money. When they don't go up -- you ...
-
I have chosen five stocks selling with dividend yields of 6%+ and with low payout ratios. The dividends of these stocks represent just 50% o...
-
As time passes, fewer investors are familiar with Peter Lynch. That’s a shame. The famous former Fidelity fund manager delivered astounding ...
-
It has been a glum time for ExxonMobil (NYSE:XOM) shareholders. Regardless of whether you’re looking at the past one year, five years, or te...
-
Buying and holding high-quality dividend stocks is one of the best ways for any investor to consistently beat the market over the long term....
-
Q3 earnings season is almost upon us, as the big banks are set to officially kick-off the season in mid-October. Many investors are keeping ...
-
This LP currently offers a 9.5% distribution yield. It has reported a distribution coverage ratio of 2.0 but this metric has proved unreliab...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.